Lung Cancer Diagnostic and Screening Market - Advancements and Growth Opportunities
Lung Cancer Diagnostic and Screening Market A) Market Overview: The global Lung Cancer Diagnostic and Screening Market is estimated to be valued at US$ 1,931.0 Mn in 2021 and is expected to exhibit a CAGR of 7.8% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights. Lung cancer is one of the most prevalent and life-threatening cancers globally. Timely diagnosis and screening play a vital role in enhancing survival rates and improving patient outcomes. The market for lung cancer diagnostic and screening products has witnessed significant advancements in recent years, with the aim of improving accuracy, efficiency, and early detection of lung cancer. These products include imaging techniques, biopsy devices, molecular diagnostic tests, and biomarker-based assays. The need for these products stems from the increasing burden of lung cancer worldwide. Factors such as a rise in smoking habits, exposure to harmful environm...